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GORAB scaffolds COPI at the trans-Golgi for
efﬁcient enzyme recycling and correct protein
glycosylation
Tomasz M. Witkos1, Wing Lee Chan2,3, Merja Joensuu4,10,11, Manuel Rhiel5, Ed Pallister6,
Jane Thomas-Oates 6, A. Paul Mould1, Alex A. Mironov1, Christophe Biot 7, Yann Guerardel 7,
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COPI is a key mediator of protein trafﬁcking within the secretory pathway. COPI is recruited
to the membrane primarily through binding to Arf GTPases, upon which it undergoes
assembly to form coated transport intermediates responsible for trafﬁcking numerous pro-
teins, including Golgi-resident enzymes. Here, we identify GORAB, the protein mutated in the
skin and bone disorder gerodermia osteodysplastica, as a component of the COPI machinery.
GORAB forms stable domains at the trans-Golgi that, via interactions with the COPI-binding
protein Scyl1, promote COPI recruitment to these domains. Pathogenic GORAB mutations
perturb Scyl1 binding or GORAB assembly into domains, indicating the importance of these
interactions. Loss of GORAB causes impairment of COPI-mediated retrieval of trans-Golgi
enzymes, resulting in a deﬁcit in glycosylation of secretory cargo proteins. Our results
therefore identify GORAB as a COPI scaffolding factor, and support the view that defective
protein glycosylation is a major disease mechanism in gerodermia osteodysplastica.
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COPI (coat protein complex I)-coated transport vesiclesmediate protein trafﬁcking in the early secretory pathway.They are responsible for retrograde transport from the
Golgi apparatus to the endoplasmic reticulum (ER)1, and for
trafﬁcking between cisternae within the Golgi apparatus2–4.
Within the Golgi, COPI-coated vesicles mediate retrograde trafﬁc
of Golgi resident enzymes5,6, and may also participate in ante-
rograde trafﬁcking of certain cargoes7,8. Although COPI is best
known for its role in vesicle trafﬁcking, recent studies also suggest
possible involvement in trafﬁcking via tubular intermediates at
the level of the Golgi stack9. In line with its trafﬁcking functions,
COPI is localized at the ER-to-Golgi intermediate compartment
(ERGIC) and Golgi apparatus, where it is abundant at the cis-
ternal rims and enriched towards the cis-side10,11. The COPI coat
is comprised of the hetero-heptameric coatomer complex2, which
is recruited from the cytosol to the membrane by the small
GTPase Arf112,13, which itself is recruited from the cytosol con-
comitant with guanosine 5'-triphosphate (GTP) loading14. Coat-
omer functions to both select cargo and promote vesicle
formation15,16, which is facilitated by the assembly of coatomer
complexes into a cage-like structure17,18. Although Arf1 is the
primary driver of coatomer recruitment, additional factors may
contribute to this process. The p24 family proteins have been
proposed to function as coatomer receptors15,19, but the extent to
which other proteins participate in coatomer recruitment or
assembly is poorly understood.
The cutis laxa syndromes are deﬁned by the presence of
loose, wrinkly, inelastic skin and can be classiﬁed into various
types depending upon clinical features and the gene that is
mutated20. The skin phenotype seen in cutis laxa is thought to
arise from defective production and/or assembly of extracellular
matrix, predominantly at the level of elastic ﬁbers21. Mutations
in several elastic ﬁber proteins have been shown to cause cutis
laxa but, interestingly, causative mutations in several cellular
proteins have also been identiﬁed20,21. Among these is GORAB,
also known as Scyl1BP1, whose mutation is responsible for
gerodermia osteodysplastica (GO)22. The hallmark symptoms
of GO are cutis laxa and osteoporosis, with reduced bone mass
and susceptibility to fractures23,24. As both symptoms are fea-
tures of aging, GO has been classiﬁed as a progeroid disorder22.
Hence, understanding how loss of GORAB leads to pathological
changes in skin and bone is likely to give new insight into how
these tissues age.
GORAB is localized to the trans-side of the Golgi apparatus22.
It is comprised of a central coiled-coil region that is responsible
for Golgi targeting, most likely via interactions with the small
GTPases Rab6 and Arf525. It has been proposed that GORAB is a
member of the golgin family of coiled-coil Golgi proteins22,
which participate in vesicle tethering26,27. GORAB has also been
proposed to function as a transcriptional activator for neurite
outgrowth28, as a modulator of MDM2 ubiquitylation that in turn
can impact upon p53 levels and apoptosis29, and has recently
been shown to play a role in centriole duplication and
ciliogenesis30,31. Despite these advances, the function of Golgi-
associated GORAB remains poorly deﬁned, and the pathogenic
mechanism underlying GO remains to be determined. Here, we
show that GORAB functions in intra-Golgi trafﬁcking as a scaf-
folding protein for COPI. It forms stable membrane domains
that, via interaction with Scyl1, stabilize COPI assembly at the
trans-Golgi. Loss of GORAB function results in reduced recycling
of trans-Golgi enzymes and improper glycosylation of cargo
proteins within both cultured cells and skin tissue. Our results
therefore identify GORAB as a player in COPI trafﬁcking, and
provide a mechanism to explain the symptoms of GO that are
also relevant to human aging.
Results
GORAB interacts with Scyl1. To gain insight into the cellular
functions of GORAB we ﬁrst investigated its interaction partners.
GORAB was ﬁrst identiﬁed as a potential binding partner for
Scyl132, also known as NTKL, but this interaction has yet to be
validated. We therefore determined whether Scyl1 is a bona ﬁde
interactor of GORAB. GORAB bound to Scyl1 in the yeast two-
hybrid system (Fig. 1a). GORAB and Scyl1 self-association was
also detected in the yeast two-hybrid system, consistent with the
presence of coiled-coil and HEAT repeat domains respectively, in
these proteins (see Fig. 1d, e)33. GORAB and Scyl1 interaction was
conﬁrmed in protein pull-down experiments (Fig. 1b). The binding
between GORAB and Scyl1 is direct, as indicated by pull-down
experiments with puriﬁed recombinant proteins (Fig. 1c). We next
mapped the interaction sites in GORAB and Scyl1. GORAB is
comprised of a central coiled-coil region, with several predicted
breaks within the coiled-coil (Fig. 1d, right), ﬂanked by non-coiled
N- and C-terminal domains. Pull-down experiments with puriﬁed
proteins indicated that the N-terminal non-coil domain is sufﬁ-
cient to bind Scyl1 (Fig. 1d, left). Scyl1 is comprised of an N-
terminal kinase-like domain that is predicted to be catalytically
inactive, centrally located HEAT repeats and a C-terminal short
coiled-coil domain followed by a dibasic binding motif for the
coatomer complex of the COPI vesicle coat34 (Fig. 1e, right).
Mapping experiments indicated that the binding site for GORAB
resides within the kinase-like domain of Scyl1 (Fig. 1e, left). Thus,
GORAB and Scyl1 are bona ﬁde binding partners that directly
interact via their respective N-terminal domains.
GORAB forms discrete domains at the trans-Golgi. GORAB
was previously localized to the trans-Golgi by immuno-
ﬂuorescence microscopy22,25. We were therefore unsurprised to
ﬁnd extensive co-localization of GORAB with the trans-Golgi
marker TGN46 by immunoﬂuorescence microscopy (Fig. 2a).
However, interestingly, closer inspection revealed that, unlike
TGN46, GORAB was not evenly distributed throughout the
trans-Golgi but rather concentrated in discrete puncta (Fig. 2a).
The puncta disappeared upon depletion of GORAB, and were
also observed with over-expressed green ﬂuorescent protein
(GFP)-tagged GORAB, conﬁrming speciﬁcity of the staining
(Fig. 2b). The discrete nature of the GORAB puncta was further
revealed by super-resolution (Fig. 2c) and immuno-electron
microscopy of both HeLa cells and dermal ﬁbroblasts (Fig. 2d, e).
The GORAB puncta are enriched at the trans-side of the Golgi
and found predominantly within the tubulo-vesicular trans-Golgi
network, as well as occasionally at the rims of the trans-most
Golgi cisternae (Fig. 2d, e).
Previous work has shown that Scyl1 distribution is biased
towards the cis-Golgi, with a signiﬁcant pool in the ERGIC34.
Labeling for Scyl1 indicated its presence in numerous puncta
within the Golgi region and in more peripheral ERGIC
(Supplementary Figure 1A). As expected, many of the Golgi
puncta overlap with the cis-Golgi marker GM130; however, there
was also signiﬁcant overlap of Scyl1 puncta with TGN46,
indicating that a pool of Scyl1 also resides at the trans-Golgi
(Supplementary Figure 1A). In agreement, we observed co-
localization of Scyl1 puncta with GORAB (Supplementary
Figure 1B, see also Fig. 2f). Although GORAB cannot bind
directly to COPI (Supplementary Figure 1C), Scyl1 does, via its
extreme C terminus (Supplementary Figures 1C and 1D)34, which
interacts with the γ-COP appendage domain (Supplementary
Figure 1E)33, and a second site within the β’-COP subunit35. We
therefore investigated whether the GORAB and Scyl1 puncta also
contained COPI. As shown in Fig. 2f, using super-resolution
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microscopy we could show that many of the GORAB- and Scyl1-
positive puncta are also positive for COPI. Interestingly, Scyl1
frequently appeared to localize between GORAB and COPI,
consistent with it bridging these two factors (Fig. 2f). We never
observed COPI in the GORAB puncta in the absence of Scyl1,
whereas the opposite could occur, consistent with the view that
Scyl1 is required for COPI association with the GORAB puncta
(Fig. 2f). We could also detect overlap of Rab6 with the GORAB
puncta, as expected from the known interaction of GORAB with
Rab622, although Rab6 was also present outside these regions,
consistent with it interacting with various effector proteins
involved in different processes at the Golgi (Fig. 2g)36.
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GORAB and Scyl1 are Arf effector proteins. A recent study
described binding of GORAB to Arf5, a Golgi-localized class II
Arf25. Given the association of GORAB, via Scyl1, with COPI,
and the fact that class I and II Arf GTPases both promote
membrane recruitment of COPI37, we re-evaluated GORAB
interaction with Arfs. Using pull-downs, we could show that
GORAB is able to bind to the class I Arfs, Arf1 and Arf3, in
addition to Arf5 (Supplementary Figure 1F). Binding occurred
only to the active, GTP-bound form and appeared strongest to
class I Arfs. We also investigated Scyl1 binding to Arfs. It has
been reported that Scyl1 binds selectively to class II Arfs, and that
binding is independent of nucleotide status33. We observed
binding of Scyl1 to Arfs, but binding was to class I Arfs only, with
strongest binding to Arf1, and binding was only to the active
GTP-bound form (Supplementary Figure 1F). Binding of both
GORAB and Scyl1 to Arf1 is direct (Supplementary Figure 1G).
These results suggest that GORAB and Scyl1 function as Arf
effector proteins. Interactions between GORAB, Scyl1, COPI and
Arf1 were not mutually exclusive, as indicated by pull-down
experiments, consistent with the proteins functioning together in
a complex (Supplementary Figure 1H).
GORAB domains are stable entities. To better understand the
nature of the GORAB puncta (membrane domains), we investi-
gated their dynamics. GFP-tagged GORAB was stably expressed
at low levels and ﬂuorescence recovery after photobleaching
(FRAP) was performed. As shown in Fig. 3a, recovery of GFP-
GORAB ﬂuorescence was slow when compared to the GFP-
tagged Golgi enzyme GalNAc-T2. This result indicates that
GORAB is stably associated with the domains, and therefore that
the domains themselves are stable entities. In contrast, recovery of
GFP-tagged Scyl1 in the Golgi region was much faster, indicating
that Scyl1 can rapidly exchange with the membrane (Fig. 3a and
Supplementary Figure 2). Co-expression with mApple-GORAB
decreased the rate of exchange of GFP-Scyl1 with the membrane,
in addition to increasing the immobile fraction (Supplementary
Figure 2). However, the rate of GFP-Scyl1 exchange remained
signiﬁcantly faster than that of GORAB (see Fig. 3a), supporting
the view that Scyl1 rapidly exchanges with stable GORAB
domains. The GORAB domains persist upon depletion of Scyl1
(Fig. 3b) or treatment of cells with brefeldin A (BFA) to remove
Golgi-associated ARF and COPI (Fig. 3c), indicating that the
domains can form independently of Scyl1, Arf and COPI.
GO disease mutations disrupt Scyl1 binding and GORAB
domains. A number of disease-causing mutations have been
described in the GORAB sequence, including several missense
mutations22,38,39. Two recently described mutations identiﬁed in
a compound heterozygous GO patient (F8L and K190del) are of
particular interest considering that neither mutation affects gross
folding of GORAB or its targeting to the Golgi apparatus (Gopal-
Kothandapani et al., in preparation) (Fig. 4a). These mutations
must therefore affect another aspect of GORAB function. Pull-
down experiments indicated that the F8L mutation does not
affect binding of GORAB to Arf1, Arf5 or Rab6, or the ability of
GORAB to self-associate (Fig. 4b). It does, however, greatly
diminish binding to Scyl1, consistent with its location in the N-
terminal Scyl1-binding region of GORAB (Fig. 4b). Surface
plasmon resonance with puriﬁed proteins indicated high afﬁnity
binding of wild-type GORAB to Scyl1 (Kd of 0.52 nM), with the
F8L mutant demonstrating a complete loss of binding (Fig. 4c
and Supplementary Figure 3A). The pathogenic effect of the F8L
mutation indicates that the GORAB–Scyl1 interaction is phy-
siologically important.
Like F8L, the K190del mutant can also bind to Arf1, Arf5 and
Rab6, although in this case binding to the Arfs is enhanced
compared to wild-type GORAB (Fig. 4b). Binding to Scyl1 is not
markedly affected by the K190del mutation, as indicated by pull-
down (Fig. 4b) and surface plasmon resonance (Fig. 4c), which
gives an identical binding afﬁnity to wild-type GORAB ( Kd =
0.52 nM) (Supplementary Figure 3B). However, strikingly, there
is a complete loss of GORAB self-association in the K190del
mutant, as indicated by pull-down (Fig. 4b). The loss of GORAB
self-association with the pathogenic K190del variant indicates this
property of the protein is of physiological importance. Expression
of the F8L and K190del variants in cells indicated that while the
F8L still localizes to discrete domains, the K190del is unable to do
so, and is evenly distributed through the trans-Golgi (Fig. 4d).
Hence, self-association of GORAB is required for the assembly of
the GORAB puncta. Together, the results indicate that both Scyl1
binding and oligomerization for stable domain assembly are
required for full functionality of GORAB in vivo.
GORAB and Scyl1 cooperate for COPI binding at trans-Golgi.
The ability of GORAB to form stable domains that also contain
Scyl1, which in turn can bind to COPI, led us to propose that
GORAB forms a scaffold that promotes COPI assembly at the
trans-Golgi. To test this hypothesis, wild-type GORAB or
mutants deﬁcient in Scyl1 binding (F8L) or oligomerization
(K190del) were expressed in cells and the stability of COPI
membrane association assessed by treating cells with BFA. As
shown in Fig. 4e, f, overexpression of wild-type GFP-tagged
GORAB stabilized COPI association with the Golgi membranes,
indicated by the retention of COPI in the perinuclear region
following 10 min of treatment with BFA. This is in contrast to
control cells, where COPI was completely cytosolic at the same
time point. The stabilization of COPI at the Golgi was lost with
the F8L or K190del mutants, indicating that both Scyl1 binding
Fig. 1 GORAB interacts directly with the NTK domain of Scyl1. a Yeast two-hybrid assay between GORAB and Scyl1 constructs. Prey (AD-GORAB or AD-
Scyl1) and bait (BD-Scyl1 or BD-GORAB) constructs were co-transformed into yeast and grown on double-drop-out (DDO) medium to verify expression of
both proteins in transformants and on selective quadruple drop-out (QDO) medium to examine protein–protein interactions. Constructs containing AD and
BD only were used as negative controls. b Pull-down assays with recombinant GORAB. Top panel: pull-down using bacterially expressed GST and GST-
GORAB as bait and sHeLa cell lysate. Bottom panel: pull-down using GST, GST-tagged GORAB or Syntaxin 1 as bait and rat liver Golgi (RLG) membrane
extract. Samples were blotted with the indicated antibodies. I input (5%), U unbound fraction (5%), B bound fraction (50%). c Pull-down assay using
puriﬁed GST-Syntaxin 1 or GST-GORAB as bait and MBP-tagged Scyl1. Samples were subjected to SDS-PAGE and analyzed by Coomassie Blue staining.
GST-tagged proteins are marked with an asterisk. BSA used as a carrier protein is marked with a circle. The faint bands running under MBP-Scyl1
correspond to likely degradation products or bacterial contaminants. d Mapping the binding site for Scyl1 on GORAB. Left, pull-down assay using puriﬁed
GST-tagged GORAB fragments as bait and MBP-tagged Scyl1. Samples were subjected to SDS-PAGE and Coomassie Blue staining. GST-tagged proteins
are marked with an asterisk. Right, schematic diagram of GST-tagged GORAB truncation constructs. e Mapping the interaction site for GORAB on Scyl1.
Left, cell lysates obtained from cells transiently expressing GFP-tagged Scyl1 constructs were used for a pull-down assay with GST or GST-GORAB as bait
and analyzed by western blotting. GST-tagged bait proteins and GFP-tagged proteins in inputs are marked with black or red asterisks respectively. Right, a
schematic diagram of GFP-tagged Scyl1 truncation constructs. CC coiled-coil region, COPI COPI binding motif
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and oligomerization of GORAB are required to elicit this effect
(Fig. 4f and Supplementary Figure 4A).
To further test the hypothesis, Scyl1 was also over-expressed in
cells. The expression of Scyl1 stabilized membrane association of
COPI upon BFA treatment, which was evident both in puncta
within the Golgi region that correspond to GORAB domains and
in more peripheral puncta likely corresponding to the ERGIC
(Fig. 4g–i). The ΔNTK Scyl1 mutant that cannot bind to GORAB,
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and the ΔCT mutant that cannot bind COPI, failed to stabilize
COPI at the Golgi (Fig. 4h and Supplementary Figure 4B),
indicating that Scyl1 must interact with GORAB and COPI to
elicit this effect. Interestingly, the ΔNTK mutant was still able to
stabilize COPI association with the ERGIC (Supplementary
Figure 4B), indicating it can stabilize COPI at this compartment
independently of GORAB, consistent with the existence of at least
two functionally distinct pools of Scyl1 in the secretory pathway.
This view is further supported by the fact that Scyl1 recruitment
to the Golgi, but not the ERGIC, requires binding to GORAB, as
shown by the lack of Golgi localization of the ΔNTK mutant
in untreated cells (Supplementary Figure 4C), and the loss of
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Golgi-associated Scyl1 in GORAB-deﬁcient ﬁbroblasts (Supple-
mentary Figure 4D). Over-expression of GORAB or Scyl1 had no
effect upon membrane recruitment or BFA sensitivity of the
trans-Golgi Arf-dependent clathrin adaptor complex AP1
(adaptor protein 1), as indicated by staining for γ-adaptin
(Supplementary Figure 5A and B). Together, these results indicate
that GORAB and Scyl1 associate to selectively stabilize recruit-
ment of COPI at the trans-Golgi.
GORAB and Scyl1 are sufﬁcient for COPI membrane binding.
We next wanted to test whether GORAB and Scyl1 are sufﬁcient
to drive COPI membrane recruitment. For this purpose GORAB
was relocated to mitochondria using a previously described
inducible targeting method40,41. In this approach, GORAB con-
taining a C-terminal FKBP tag was expressed in cells co-
expressing mitochondrial targeted FRB, which binds to FKBP
only in the presence of rapamycin, allowing inducible relocation
of GORAB to mitochondria upon rapamycin addition (Fig. 5a).
For these experiments we used the K190del mutant, which gave a
clearer mitochondrial targeting, although similar results were
obtained with wild-type GORAB. Cells were also treated with
nocodazole to depolymerize microtubules and disperse the Golgi,
giving a clearer readout41. In the absence of rapamycin, GORAB
was localized to Golgi elements, where it co-localized with GFP-
Scyl1, as expected (Fig. 5b). Upon addition of rapamycin,
GORAB was efﬁciently relocated to mitochondria, and co-
expressed GFP-Scyl1 (Fig. 5b), or endogenous Scyl1 (Fig. 5c), also
redistributed to the GORAB-positive mitochondrial membrane.
Golgi markers were absent from mitochondria under these con-
ditions, excluding the possibility of gross distribution of Golgi
elements (Supplementary Figure 6A). Endogenous COPI was
partially localized to the GORAB and GFP-Scyl1 containing
mitochondria, although there remained a signiﬁcant amount in
cytoplasmic puncta, likely corresponding to the ERGIC and dis-
persed Golgi elements (Fig. 5d). This result suggested that
GORAB and Scyl1 can recruit COPI to mitochondria. To further
assess this possibility, cells were treated with BFA to remove
COPI from the Golgi and ERGIC. Under these conditions, there
was almost complete redistribution of COPI to the mitochondria
(Fig. 5d). Mitochondrial recruitment of COPI was not obvious in
the absence of GFP-Scyl1 co-expression (Supplementary Fig-
ure 6B), likely due to the limiting amounts of endogenous Scyl1 in
the cell compared to COPI42. Together, the results indicate that
co-expressed GORAB and Scyl1 are sufﬁcient to recruit COPI to
the mitochondrial membrane. Moreover, it shows that COPI can
be recruited to the GORAB-Scyl1 complex in the absence of
membrane-associated Arf, which is further supported by the
absence of mitochondrial Arf under conditions where COPI is
recruited there (Supplementary Figure 6C). As expected, Scyl1
deﬁcient in GORAB (ΔNTK) binding failed to associate with
mitochondria and recruit COPI, while the COPI binding mutant
(ΔCT) was recruited to mitochondria but failed to recruit COPI
(Supplementary Figure 7). Thus, GORAB recruits Scyl1, which in
turn recruits COPI. In the same assay, we failed to observe
mitochondrial relocation of AP1 (Supplementary Figure 8A). We
also failed to observe GORAB-dependent mitochondrial recruit-
ment of GFP-tagged Scyl2 or Scyl3, the latter of which has
recently been proposed to function redundantly with Scyl143
(Supplementary Figure 8B). Lack of interaction between GORAB
and Scyl3 was further conﬁrmed in a pull-down experiment
(Supplementary Figure 8C). Thus, GORAB selectively interacts
with Scyl1, and the GORAB-Scyl1 complex is sufﬁcient to drive
selective membrane association of COPI (Supplementary
Figure 8D).
Liposome binding experiments further supported a role for
Scyl1 in promoting COPI association with membranes. As shown
previously19,44, incubation of synthetic liposomes with puriﬁed
coatomer and Arf1 leads to recruitment of both proteins to the
liposome membrane in a GTP-dependent manner (Fig. 6a). Scyl1
is also recruited to liposomes in the presence of Arf1 (Fig. 6a),
consistent with its ability to bind directly to Arf1-GTP
(Supplementary Figure 1G). When Scyl1 is added to liposomes
in the presence of Arf1 and coatomer, Arf1 recruitment is not
signiﬁcantly altered, but recruitment of coatomer is increased
nearly two-fold (Fig. 6b, c). Scyl1 is therefore able to enhance
COPI recruitment to membranes in a manner independent of
Arf1 association.
Loss of GORAB causes defective protein glycosylation. COPI is
required for recycling of Golgi resident proteins, including the
numerous enzymes that process glycans on cargo proteins and
lipids as they transit the Golgi apparatus45. We therefore hypo-
thesized that loss of GORAB would cause altered processing of
cargo proteins due to impaired enzyme recycling. To test this
possibility, dermal ﬁbroblasts from wild-type or GO donors were
subjected to N-glycomics analysis by mass spectrometry. This
revealed a reduction in abundance of complex terminally sialy-
lated glycans in the GO ﬁbroblasts compared to wild-type con-
trols, with a small reciprocal increase in their galactose
terminated precursors, suggesting a deﬁcit in addition of terminal
sialic acid (N-acetylneuraminic acid (NeuAc)) residues in the GO
cells (Fig. 7a). The deﬁcit in terminal sialylation was conﬁrmed
using lectins. Immunoﬂuorescence microscopy with ﬂuorescently
tagged Maackia Amurensis Lectin I (MALI) and Sambucus Nigra
(SNA) lectins that speciﬁcally recognize sialic acid attached
to terminal galactose or GalNAc via an α−2,3 linkage (MAL) or
Fig. 4 Effect of pathogenic missense mutations upon GORAB behavior. a Location of known missense and single base deletion GORAB mutations in GO
patients. Coiled-coil domains are depicted as orange rectangles. b Interaction of GORAB variants with GST-tagged bait proteins, as indicated, using cell
lysates from RPE-1 cells expressing the indicated GFP-tagged GORAB variants. Inputs (5%) and bound fractions (50%) were blotted for GFP. c Surface
plasmon resonance analysis of GORAB-Scyl1 binding. Top, experimental setup with a GLH sensor chip, cross-linked anti-MBP antibody, MBP-Scyl1 as
bound ligand and GST-GORAB variants as analyte. Bottom, binding of GST-GORAB variants at 30 nM concentration for 120 s followed by 600 s
disassociation. Similar results were obtained in three separate experiments. d Golgi localization of GFP-tagged GORAB variants using STED microscopy.
RPE-1 cells were ﬁxed and labeled with TGN46 antibodies. Scale bar, 5 µm. e COPI subcellular localization in HeLaM cells transfected with GFP or GFP-
GORAB and incubated for 10 min with 5 µg/mL BFA. Cells were labeled with antibodies to β’-COP and GM130. Scale bar, 10 µm. Dotted line marks the
nucleus. f Quantiﬁcation of COPI retention in the Golgi region from e. Error bars represent mean ± SD, n= 100 cells in each of 3 independent experiments,
*p≤ 0.05 and ***p < 0.001, unpaired t-test. g COPI subcellular localization in HeLaM cells transfected with GFP or GFP-Scyl1 ﬁxed 10min after incubation
with 5 μg/mL BFA. Cells were labeled with antibodies to β’-COP and GM130. Scale bar, 10 µm. Dotted line marks the nucleus. h Quantiﬁcation of COPI
retention in the Golgi region from g. Error bars represent mean ± SD, n= 100 cells in each of 3 independent experiments, ***p < 0.001, unpaired t-test. i Co-
localization between GFP-Scyl1, β’-COP and GORAB in HeLaM cells ﬁxed 10min after incubation with 5 μg/mL BFA. Cells were labeled with antibodies to
GORAB and β’-COP. Scale bar, 10 µm. Dotted line marks the cell boundary. The white line indicates the pixels used for the RGB ﬂuorescence intensity
proﬁle plot on the right, which is representative of data from n= 20 cells
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α−2,6 linkage (SNA), respectively, showed a signiﬁcant reduction
in SNA staining in GO ﬁbroblasts compared to controls (Fig. 7b,
c). In contrast, MAL staining was comparable between control
and GO cells, indicating a preferential deﬁcit in α−2,6 linkage of
sialic acid to terminal galactose. Reduced SNA lectin staining was
also evident by ﬂuorescence-activated cell sorting analysis of GO
compared to control ﬁbroblasts (Fig. 7d). To more directly assess
glycosylation efﬁciency, cells were metabolically labeled with
alkyne-tagged NeuAc precursor N-(4-pentynoyl) mannosamine
(ManNAl), which allows ﬂuorescence detection of sialic
acid incorporation into glycoproteins within living cells46. GO
cells incorporated less ﬂuorescently tagged sialic acid at the
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trans-Golgi compared to wild-type controls, indicating reduced
sialylation upon loss of GORAB (Fig. 7e, f).
To assess whether loss of GORAB also caused altered
glycosylation in vivo, skin samples were obtained from a
GORAB-deﬁcient knockout mouse47 and analyzed by glycomics.
The analysis revealed a striking reduction in complex N-glycans,
which includes the species with terminal sialic acid residues
(Fig. 7g), and a reciprocal increase in Mann5 oligomannose
species (Fig. 7g). Blotting of mouse skin samples with lectins
corroborated the mass spectrometry data, showing a reduction in
high molecular weight species detected by the SNA and E-PHA
lectins, which label α−2,6 linked terminal sialic acid and complex
N-glycan chains respectively (Fig. 7h and i). Loss of GORAB
therefore leads to perturbation of protein glycosylation in the
Golgi apparatus, with a reduced abundance of complex and
terminally modiﬁed glycoproteins. The phenotype is evident
in vitro but appears to be more penetrant in vivo.
Mislocalization of sialyltransferase upon loss of GORAB. The
glycomics and lectin data suggested a deﬁcit in recycling of
enzymes involved in generating complex terminally modiﬁed
glycan species, most strikingly terminal α−2,6 sialylation, in GO
cells. Defective recycling would be expected to cause a shift in
enzyme distribution to later Golgi compartments, or even to post-
Golgi compartments. Due to the lack of reagents to label endo-
genous ST6GAL1 and ST6GALII, we generated a HeLa cell line
stably expressing horseradish peroxidase (HRP) fused to
ST6GALI (designated ST-HRP). This fusion allows localization to
be performed at high resolution using cytochemical staining
followed by electron microscopy, and has previously been used to
track trans-Golgi morphology during the cell cycle48. In control
cells treated with luciferase control small interfering RNA
(siRNA) (Fig. 8a), ST-HRP was predominantly localized to the
trans-most cisterna of the Golgi stack, with some additional signal
present in adjacent tubulo-vesicular proﬁles corresponding to the
trans-Golgi network (TGN) (Fig. 8b, c). Upon depletion of
GORAB (Fig. 8a), ST-HRP exhibited a shift in distribution
towards the TGN, as well as additional circular proﬁles within the
vicinity of the TGN (Fig. 8b, c). This effect upon ST-HRP dis-
tribution was not due to a change in Golgi morphology, which
was unaffected by GORAB depletion in these cells (Fig. 8b). Like
GORAB, depletion of Scyl1 (Fig. 8a) also resulted in a shift of ST-
HRP to later compartments (Fig. 8b, c). As a positive control, we
also depleted the Cog3 subunit of the conserved oligomeric Golgi
(COG) complex (Fig. 8a), which is a tethering complex required
for COPI-dependent Golgi enzyme recycling45. As reported
previously49, Cog3 depletion caused extensive vesiculation of
Golgi membranes, with a certain proportion of the vesicles con-
taining ST-HRP, indicating a failure to tether trans-Golgi-derived
vesicles (Fig. 8b, c). In summary, these results reveal that both
GORAB and Scyl1 are required to maintain a normal ST-HRP
distribution within the Golgi apparatus, as would be expected if
they functioned together in COPI-mediated enzyme recycling at
the trans-Golgi.
Altered Golgi morphology upon loss of GORAB. Although the
Golgi appeared morphologically normal in GORAB-depleted
HeLa cells, we wanted to determine whether the Golgi organi-
zation is altered by loss of GORAB in dermal ﬁbroblasts, which
represent a better model of the human disease. Dermal ﬁbroblasts
Fig. 5 GORAB, via Scyl1, is sufﬁcient to recruit COPI to membranes. a A schematic diagram depicting the mitochondrial relocation assay where the addition
of rapamycin induces mitochondrial relocation of FKBP-tagged GORAB, allowing for recruitment of associated factors to this compartment. b Relocation of
GORAB-mycFKBP and co-expressed GFP-Scyl1 to mitochondria. HeLaM cells co-transfected with mito-FRB and GORABK190del-mycFKBP constructs were
pretreated with 2.5 µg/mL nocodazole for 2 h and further incubated with 1 µM rapamycin or DMSO for 3 h prior to ﬁxation. Cells were labeled with
antibodies to myc and mtHsp70. c Relocation of endogenous Scyl1 to mitochondria by GORAB-mycFKBP. HeLaM cells co-transfected with mito-FRB and
GORAB-mycFKBP and treated as described in b and labeled with antibodies to endogenous Scyl1 and the Golgi marker β4GalT1. d Relocation of COPI to
mitochondria by GORAB-mycFKBP. HeLaM cells co-transfected with mito-FRB, GORABK190del-mycFKBP and GFP-Scyl1 were treated as in b, and
additionally with 5 µg/mL BFA for 15 min (lower panel only). Cells were labeled with antibodies to β’-COP and myc. In b–d, scale bars are 10 µm and white
lines indicate the pixels used for the RGB ﬂuorescence intensity proﬁle plots shown on the right, which are representative of data from n= 20 cells
Arf1 ε-COPδ-COP
MBP-IPIP27A
MBP-Scyl1
**
***
%
 o
f i
np
ut
 in
 fl
oa
te
d 
fra
ct
io
n
20
15
10
5
0
+
+ + +
– +–
–+
– +– + MBP-Scyl1
Coatomer
myr-Arf1 WT
–
+
GTPγS
+
Arf1
MBP
ε-COP
Floats (40%)Inputs (2%)
+
+ + +
– +–
–+
– +– +
–
+
+
20
15
37
150
kDa 20
15
37
Arf1
ε-COP
75
δ-COP
MBP150
Floats (40%)
+ + +
+– +
+ +
+ +–
– –+
+ + +
+– +
+ +
+ +–
– –+
+
MBP-IPIP27A
MBP-Scyl1
Coatomer
myr-Arf1 WT
GTPγS
+
Inputs (2%)
kDa
a b c
Fig. 6 Scyl1-dependent recruitment of COPI to artiﬁcial membranes. a Liposome recruitment assay with puriﬁed MBP-Scyl1, myr-Arf1 and recombinant
coatomer. Inputs (2%) and membrane-bound fractions (40%) were subjected to SDS-PAGE and blotted for MBP, ε-COP and Arf1. b Liposome recruitment
assay with puriﬁed MBP-IPIP27A (as negative control), MBP-Scyl1 and myr-Arf1 and recombinant coatomer. Inputs (2%) and membrane-bound fractions
(40%) were subjected to SDS-PAGE and blotted for MBP, δ-COP, ε-COP and Arf1. c Quantiﬁcation of recruitment of Arf1 and coatomer (δ-COP, ε-COP) to
liposomes in the presence of MBP-IPIP27A and MBP-Scyl1. Error bars represent mean ± SD, n= 6 independent experiments, **p < 0.01, ***p < 0.001,
unpaired t-test
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-08044-6
10 NATURE COMMUNICATIONS |          (2019) 10:127 | https://doi.org/10.1038/s41467-018-08044-6 | www.nature.com/naturecommunications
secrete high amounts of extracellular matrix proteins and may
therefore be more sensitive to perturbation of intra-Golgi trafﬁc
than HeLa cells, which have a lower secretory capacity. As
expected, in control ﬁbroblasts, the Golgi apparatus formed a
characteristic Golgi stack, with clearly discernable cisternae sur-
rounded by small spherical proﬁles that likely correspond to
transport vesicles (Fig. 8d). Although some cisternal distensions
were observed in control ﬁbroblasts, in GO ﬁbroblasts, the dis-
tensions were larger and more numerous, and were restricted to
one side of the Golgi, most likely the TGN and the trans-most
cisternae, where they were often present at the rims (Fig. 8d, e).
Hence, GORAB appears to be required to maintain normal
organization of the trans-Golgi in dermal ﬁbroblasts, which is
consistent with a role for the protein in intra-Golgi trafﬁcking at
this compartment.
Discussion
In this study we have identiﬁed GORAB as a factor in COPI
trafﬁcking at the Golgi apparatus. Together with the COPI
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binding protein Scyl1, it scaffolds COPI assembly at discrete
regions (domains) of the trans-Golgi. The GORAB domains are
functionally important as their loss, or their inability to interact
with Scyl1 and therefore COPI, causes GO in humans. The
GORAB domains are restricted to the trans-Golgi despite COPI
being more abundant at the cis-side of the Golgi apparatus and
the ERGIC. This observation suggests that COPI requires an extra
degree of organization to function efﬁciently at the trans-Golgi
compared to earlier in the secretory pathway. The TGN is a
complex compartment with multiple functional domains50,51.
Moreover, the predominant Arf binding coat proteins at the TGN
are AP1 and the GGAs51. Hence, GORAB may improve the
efﬁciency of COPI assembly at the TGN by recruiting Scyl1 and
GTP-loaded Arf1, both of which bind COPI, into discrete
domains (Fig. 8f). The high local concentration of Scyl1 and Arf1
in these domains would allow the coincident detection of both
proteins, and favor the selective concentration of COPI, at the
expense of AP1. Because GORAB and Scyl1 are oligomers,
recruitment of COPI is likely to be further enhanced by the
multivalent nature of the interactions between these proteins. The
ability of Scyl1 to bind two distinct sites in COPI also suggests
that it may contribute to the coat assembly process by potentially
bridging individual coatomer complexes33.
GORAB is required for recruitment of Scyl1 to the trans-Golgi.
However, Scyl1 is also present at the cis-Golgi and ERGIC34, and
recruitment of Scyl1 to these earlier compartments is independent
of GORAB. There are therefore two distinct pools of Scyl1 in the
cell, a GORAB-dependent trans-Golgi pool and a separate
GORAB-independent cis-Golgi/ERGIC pool. How Scyl1 is
recruited to the cis-Golgi and ERGIC is currently unknown. We
have shown that it binds to GTP-loaded Arf1, but the persistent
association of Scyl1 with the ERGIC upon BFA treatment indi-
cates that another binding factor must exist34. A potential can-
didate is FTCD/58K, which can bind Scyl152, but this protein
appears to be absent from the ERGIC, suggesting that another, as
yet unidentiﬁed, protein recruits Scyl1 to this compartment.
Regardless of how Scyl1 is recruited to the membrane, its role in
promoting COPI assembly appears to be conserved at the dif-
ferent locations. Scyl1 may therefore act as a COPI ‘receptor’, as
has been proposed for p2315,19. These proteins may even act in
tandem at the cis-Golgi and ERGIC to promote COPI recruit-
ment, whereas at the trans-Golgi, Scyl1 presumably acts inde-
pendently of p23, which is not present there.
The other two members of the Scyl family, Scyl2 and Scyl3, are
both also present at the Golgi apparatus43,53,54. Scyl2, also known
as CVAK104, functions as a clathrin adaptor at the trans-Golgi,
and participates in sorting of SNAREs into clathrin-coated
vesicles that shuttle between the TGN and endosomes53,55. Its
function is therefore distinct from that of Scyl1. In contrast to
Scyl2, but similar to Scyl1, Scyl3 appears able to bind COPI, and
knockout studies in mice indicate functional redundancy between
the Scyl1 and Scyl3, at least in neurons43. Hence, these proteins
may share overlapping functionality. However, our results, which
show that neither Scyl2 nor Scyl3 can bind GORAB, indicate that
Scyl1 has a function distinct from that of Scyl3, namely in the
scaffolding of COPI into discrete membrane domains at the
trans-Golgi. It will be interesting to further analyze the role of
Scyl3 in COPI trafﬁc, and also to compare how the loss of Scyl1
or Scyl3 affects COPI trafﬁcking in different cell types.
Loss of Scyl1 in humans manifests as CALFAN syndrome,
which causes neurodegeneration, similar to that seen in Scyl1-
deﬁcient mice56 and liver failure, with some patients also showing
skeletal abnormalities57,58. The different symptoms in CALFAN
syndrome compared to GO could be explained by Scyl1 func-
tioning earlier in the secretory pathway, at the ERGIC and cis-
Golgi, in addition to its GORAB-speciﬁc function at the trans-
Golgi34,52. This is likely to differentially affect secretory trafﬁc,
which may be further complicated by differences in the extent to
which loss of Scyl1 or GORAB affects trafﬁcking in different cell
types, also considering the possible functional overlap with
Scyl343. A better understanding of the disease mechanisms in
CALFAN and GO patients will help resolve these issues.
We observed impairment of protein glycosylation in GO cells
and in a GORAB knockout mouse. Thus, GO can be considered
as a congenital disorder of glycosylation (CDG)59. Type II CDGs
are associated with defects in glycan processing59, and we propose
that GO is included in this category of CDGs. Interestingly,
several type II CDGs are due to mutations in the COG complex,
which is required for tethering of intra-Golgi transport vesicles60.
Loss of COG leads to impaired enzyme recycling, resulting in
improper cargo protein glycosylation45. Although there is some
variability in the severity of the phenotype depending upon the
nature of the COG mutation, CDGs due to COG mutations tend
to be more severe than GO45, reﬂecting the more widespread role
for COG in enzyme recycling throughout the Golgi stack. Loss of
GORAB tends to cause a milder phenotype, as would be expected
from its exclusive role in the recycling of trans-Golgi enzymes.
Interestingly, wrinkled and lax skin, as seen in GO, is also evident
in autosomal recessive cutis laxa type 2 (ARCL2), which is caused
by mutation of the ATP6V0A2 subunit of the vacuolar ATPase61.
The vacuolar ATPase is required to maintain an acidic intra-
luminal Golgi pH that is optimal for cargo protein glycosylation.
Hence, the increased intraluminal Golgi pH upon loss of
ATP6V0A2 is thought to cause impaired glycosylation and
Fig. 7 Loss of GORAB causes defective terminal N-glycosylation of proteins. a N-glycome analysis of WT and GO ﬁbroblasts. Quantiﬁcation of relative
intensities of MALDI-TOF-MS signals for N-glycan species detected in lysates from wild-type (N= 3 cell lines) and GO ﬁbroblasts (N= 4 cell lines). Error
bars represent the mean ± SEM from 4 independent experiments, *p < 0.05, unpaired t-test. GlcNAc N-acetylglucosamine, NeuAc N-acetylneuraminic acid,
NeuGc N-glycolylneuraminic acid. Yellow shading indicates differences between WT and GO ﬁbroblasts. b Analysis of sialylated plasma membrane
proteins in WT and GO ﬁbroblasts using MAL and SNA lectins. Top, glycan chains recognized by the lectins. Bottom, non-permeabilized ﬁbroblasts stained
with FITC-conjugated lectins. Scale bar, 10 µm. c Quantiﬁcation of ﬂuorescence intensities from b (150 cells analyzed per cell line in each of 3 independent
experiments, min to max box and whisker plot, **p < 0.01, Mann–Whitney U test. d Representative ﬂow cytometry histogram of WT and GO ﬁbroblasts
(N= 3 cell lines) stained with FITC-conjugated MAL and SNA lectins. e Analysis of metabolic labeling of WT and GO ﬁbroblasts with alkynyl-tagged sialic
acid precursor ManNAl. Co-cultured WT and GO cells were incubated with ManNAI for 10 h, ﬁxed and labeled with antibodies to GORAB and TGN46.
Scale bar, 10 µm. f Quantiﬁcation of ManNAI labeling assessed as ﬂuorescence intensity against that of a Golgi marker, with 300 cells analyzed per cell line
in 3 independent experiments, min to max box and whisker plot, ***p < 0.001, Mann–Whitney U test. g N-glycome analysis of control and GorabNull mouse
skin tissue. Symbols representing monosaccharide residues are as in a. Yellow shading indicates N-glycans different between control and GorabNull
samples. h, i Left, lectin blot analysis of skin lysates of control and GorabNull E18.5 embryos with E-PHA (h) or SNA lectin (i). Right, quantiﬁcation of E-PHA
(h) or SNA (i) levels. Error bars represent the mean+ SD, n= 4 independent experiments, *p < 0.05, **p < 0.01, unpaired t-test. In a, g, the glycan colored
symbols are drawn according to the Symbol Nomenclature For Glycans convention. The structures shown are those most probable for compositions
determined from accurate m/z measurements on the basis of the well-accepted biosynthetic route for N-glycans. Glycan assignments and accompanying
masses in g are shown in Supplementary Table 1
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trafﬁcking of secretory cargoes61,62. As seen in GO, sialylation of
cargo proteins is particularly affected by loss of ATPV0A261,
suggesting with a common pathogenic mechanism in both
ARCL2 and GO.
Although we show here that the modiﬁcation of N-linked
glycans is impaired by loss of GORAB, it is likely that trans-Golgi
enzymes involved in the modiﬁcation and processing of O-linked
glycan chains, such as those found in proteoglycans, is also
affected. Indeed, our analysis of the small leucine-rich
proteoglycans (SLRPs) decorin and biglycan in the skin and bone
of GORAB-deﬁcient mice has shown a dramatic reduction in the
degree of glycanation of these proteins47. SLRPs are abundant
proteins of the extracellular matrix, where they associate with
collagen to stabilize matrix assembly63. Loss of SLRPs causes
pathological changes in skin, skeleton and cardiovascular tissues
in mouse models and human patients63. SLRPs are particularly
sensitive to mutation of enzymes involved in glycosaminoglycan
(GAG) chain synthesis64–67, and defects in several of these
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enzymes cause connective tissue disorders with similar clinical
features to those seen in GO64,66,67. It is therefore likely that
impaired glycanation of decorin and possibly other proteogly-
cans, due to defective recycling of glycanation enzymes, con-
tributes to the skin and bone phenotypes seen in GO.
GORAB is widely expressed in the body22, and we show here
that it functions in a universally important process, namely
COPI-mediated intra-Golgi trafﬁcking. This raises the question as
to why GO is manifest in the skin and bones. One possibility is
that loss of GORAB is compensated for by another protein in
most tissues. However, GORAB does not have any obvious
functional homologs, arguing against this possibility. Rather, we
favor the idea that the tissues most affected by loss of GORAB,
i.e., skin and bone, are those that are most sensitive to impaired
glycosylation and glycanation of cargo proteins. These tissues
comprise large amounts of extracellular matrix, and matrix
assembly and maintenance are susceptible to impairment of
matrix protein glycosylation and glycanation. Hence, loss of
GORAB manifests primarily in these matrix-rich tissues. We have
shown that decorin is a relevant substrate in this regard47, but
other matrix proteins are also likely to be affected, especially those
that undergo extensive sialylation or glycanation.
A recent study using both Drosophila embryos and human
tissue culture cells has uncovered a role for GORAB in centriole
duplication, which is distinct from its function at the Golgi
apparatus31. This suggests that centriolar defects may contribute
to the GO phenotype. However, analysis of a pathogenic GO
mutation that disrupts Golgi targeting (A220P) showed no effect
upon GORAB function at the centriole. This ﬁnding is consistent
with Golgi dysfunction being the primary cause of GO, although
we cannot exclude an involvement of centriolar defects in GO
pathology, possibly through defects at the cilium30,31. Interest-
ingly, interference with Golgi targeting of Drosophila Gorab
resulted in a spermatogenesis defect very similar to that seen in
COPI-deﬁcient ﬂies, consistent with a functional association
between GORAB and COPI being conserved in evolution31,68.
Methods
Reagents and antibodies. Reagents were obtained from Sigma-Aldrich, Merck or
Thermo Fisher Scientiﬁc unless otherwise speciﬁed. Primary antibodies used in this
study are detailed in Supplementary Table 2. Alexa 488-conjugated streptavidin,
Alexa 488-, 546-, 555-, 594- and 647-conjugated, and Cy3- and Cy5-conjugated
secondary antibodies were from Molecular Probes (Thermo Fisher Scientiﬁc) and
from Jackson ImmunoResearch Laboratories, respectively. HRP-conjugated sec-
ondary antibodies were from Sigma. HRP-conjugated streptavidin was from
GenScript.
Molecular biology. GORAB and Scyl1 cDNA sequences were obtained from the I.
M.A.G.E. Consortium (Source Biosciences). All amino acid positions of GORAB
mentioned in this study refer to the 369 amino acid protein, which originates from
the ENST00000367763.7 transcript using the second predicted start codon, which is
the correct translation start site22,25. Using standard molecular biology techniques
full-length and truncated GORAB and Scyl1 sequences were subcloned into pEGFP-
C3 (Clontech Laboratories), pGADT7 and pGBKT7 (BD Biosciences), pFAT2 (a
modiﬁed pGAT2 vector) and pMAL-C2 (New England Biolabs) for mammalian
expression, yeast two-hybrid analysis, and bacterial expression, respectively. Mis-
sense patient mutations were introduced by site-directed mutagenesis performed
using PfuTurbo DNA polymerase adapted from the Quikchange site-directed
mutagenesis method (Agilent Technologies). To make GORAB-mycFKBP con-
structs, GORAB and mycFKBP fragments were inserted into pcDNA3.1 vector
(Invitrogen). Vectors encoding GST-tagged Δ14Arf1 (Q71L and T31N) were a gift
from Dr. Sean Munro (Laboratory of Molecular Biology, Cambridge, UK). Arf1 was
subcloned into pET24a (Merck) and pcDNA3.1 HA-tag (Invitrogen). GST-tagged
Δ14Arf3-GTP (Q71L) and GDP (T31N), Δ14Arf4-GTP (Q71L) and GDP (T31N)
and Δ14Arf5-GTP (Q71L) and GDP (T31N) were subcloned from vectors obtained
from Dr. Elizabeth Sztul (University of Alabama, Birmingham, USA). Vectors
encoding GST-tagged γ−1 appendage, Rab6-GTP (Q72L) and GDP (T27N), Bet1
and syntaxin-1 have been described previously69–71. pSRα-SialylT-HRP plasmid
containing cytoplasmic tail, transmembrane domain and part of luminal domain of
ST6GAL1 fused with HRP has been previously described48. Mito-FRB plasmid was
a gift from Dr. Stephen Royle (University of Warwick, Warwick, UK). Vector
encoding GFP-Scyl2 was obtained from Dr Ernst Ungewickell (Hannover Medical
School, Hannover, Germany). Vector encoding Scyl3-myc was obtained from Dr.
Rick Thorne (Newcastle, New South Wales, Australia). Scyl3 was subcloned into
pEGFP-N3 (Clontech Laboratories). Primer sequences used for molecular cloning
are described in Supplementary Table 3.
Cell culture, transfection, RNAi and drug treatments. Written informed consent
for molecular studies was obtained from control and affected individuals or from
their legal representatives. Dermal ﬁbroblasts were obtained by standard punch
biopsy. All studies on patient ﬁbroblasts were carried out in accordance with local
ethical regulations, with approval from the University of Manchester Research
Ethics Committee. Patient ﬁbroblasts were also obtained from the cell line and
DNA Bank from Patients Affected by Genetic Diseases (Genova, Italy, codes:
FFF0631984 and FFF0731991). All cells were grown at 37 °C and 5% CO2. HeLa
(ATCC CCL-2), HeLaM (RRID:CVCL_R965), HEK293 (Cell Biolabs, LTV-100)
and human dermal ﬁbroblasts were grown in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with 10% (vol/vol) fetal bovine serum (FBS), 1 mM L-
glutamine and penicillin–streptomycin mix. Non-essential amino acid solution was
added to human skin ﬁbroblasts, while HeLa cells stably expressing ST6GALI-HRP
(ST-HRP) and HeLa cells stably expressing GFP-GalNAc-T2 (Dr. Brian Storrie,
University of Arkansas for Medical Sciences, Little Rock, AK) were supplemented
with 1 mg/mL and 0.5 mg/mL G418, respectively. hTERT-RPE-1 cells (ATCC)
were grown in 1:1 mix of Ham’s F12 and DMEM supplemented with 10% (vol/vol)
FBS, 1 mM L-glutamine, penicillin–streptomycin mix and 10 µM hygromycin B.
Transient transfection of plasmid DNA was performed using FuGene HD (Pro-
mega) according to the manufacturer’s instructions and cells were assayed 24–48 h
post transfection. For RNA interference (RNAi), HeLa ST-HRP cells were trans-
fected with 20 nM siRNA duplexes using INTERFERin (Polyplus Transfection)
according to the manufacturer’s instructions and were analyzed 72 h post trans-
fection. GORAB was targeted with ON-TARGETplus SMARTpool (pool of four
siRNAs; L-016142; sense: AGCUAGAUAUACAGCGCAA, CAACAACUUCAGC
GAGAAA, CAACAAGAACAACGGCUAA and CCAUGAAACUAAAGCGG
AU), Scyl1 with ON-TARGETplus SMARTpool (pool of four siRNAs; L-005373,
sense: GCUCUGCGGUCUCACUGUA, GAAGUGGUCAGCAGACAUG, CAAG
UGAGCCGUGCUAGUC and GCUACACCAGAUCGUGAAA), and Cog3 with a
previously described siRNA (sense: AGACUUGUGCAGUUUAACA49). all pur-
chased from Dharmacon (Thermo Fisher Scientiﬁc). Luciferase siRNA (GL2;
Eurogentec, sense: CGUACGCGGAAUACUUCGA) was used as negative control.
For the mitochondrial relocation assay, HeLaM cells were treated with 2.5 μg/mL
nocodazole for 2 h, followed by addition of 1 μM rapamycin (Calbiochem) for
3 h to induce targeting of GORAB K190del-mycFKBP onto mitochondrial outer
membranes. In some experiments cells were incubated with 5 μg/mL brefeldin A
(Sigma) for an indicated time period.
Fig. 8 Loss of GORAB alters SialylT localization and Golgi ultrastructure. a Knock-down of GORAB, Scyl1 and Cog3 proteins in HeLa SialylT-HRP cells.
SiRNA-transfected HeLa SialylT-HRP cells were lysed, subjected to SDS-PAGE and blotted for GORAB, Scyl1, Cog3 and GAPDH. b Representative EM
micrographs depict localization of SialylT-HRP, detected using the DAB reaction to generate electron dense product, in HeLa SialylT-HRP cells transfected
with the indicated siRNAs. Scale bar, 500 nm. c Quantiﬁcation of SialylT-HRP distribution in siRNA-treated HeLa SialylT-HRP cells (n= 22 cells per
condition, ***p < 0.001, chi-square test). d Representative conventional thin section EM micrographs of Golgi ultrastructure in WT (n= 4 cell lines) and GO
ﬁbroblasts (n= 3 cell lines). Enlarged proﬁles within Golgi cisternae are marked with a red asterisk. Scale bar, 500 nm. e Quantiﬁcation of cells with dilated
cisternae. Error bars represent mean ± SD, n= 25 cells per cell line, **p < 0.01, chi-square test. f Proposed model for GORAB function in COPI-mediated
trafﬁcking at the trans-Golgi. (I) GORAB oligomers are stably associated with the trans-Golgi membrane, forming discrete domains, while GTP loading of
Arf GTPase leads to its association with the membrane. (II) Membrane-associated GORAB oligomers recruit Scyl1 and locally concentrate GTP-bound Arf
in the domains, facilitating the efﬁcient recruitment of coatomer by coincident detection. (III) Coatomer accumulates in the domains and begins to self-
assemble. (IV) Coatomer assembly leads to cargo incorporation into a newly forming COPI vesicle. (V) GORAB may stabilize coatomer assembly by
remaining associated with the bud neck during vesicle formation. (V) The completed COPI vesicle detaches from the membrane alongside Scyl1, while
GORAB stays at the membrane ready to initiate the biogenesis of a new COPI vesicle
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Lentivirus production. HEK293 cells were seeded on 10 cm dishes 24 h prior to
transfection. For each dish, 6 µg of pXLG3-GORAB plasmid, 4.5 µg of psPAX2
packaging plasmid and 3 µg of pM2G envelope plasmid were transfected into
HEK293 cells using 27 µL of polyethylenimine mix (1 mg/mL in 150 mM NaCl)
and antibiotic-free medium. At 6–8 h after transfection, the medium was replaced.
The following day, transfected cells were supplemented with 100 µL of 1 M sodium
butyrate (Merck) for 6–8 h and the medium was replaced. At 72 h after the initial
transfection, the virus-containing medium was collected and precleared by cen-
trifugation (10 min, room temperature (RT) at 2700 × g in Rotoﬁx 32 A centrifuge
(Hettich Centrifuges)) and the supernatant was ﬁltered through a 0.44 µm syringe-
driven ﬁlter unit. Then, 1–3 mL of virus-containing medium was used for cell
transduction.
Protein-binding assays. Cells were lysed in HMNT buffer (20 mM HEPES-KOH,
pH 7.4, 5 mM MgCl2, 0.1 M NaCl, 0.5% (wt/vol) Triton X-100) supplemented with
protease inhibitor cocktail (Calbiochem) and precleared by centrifugation at
16,000 × g for 15 min at 4 °C in a microfuge. For pull-down experiments, 40 µg of
GST-tagged bait protein bound to 20 µL of glutathione resin was incubated with
cell lysate (300–500 µL of lysate for exogenously expressed proteins; 2–3 mg of
sHeLa cell lysate for endogenously expressed proteins) for 4 h at 4 °C with agita-
tion. Bound proteins were eluted in SDS sample buffer analyzed by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) with western blotting.
Proteins from rat liver Golgi membranes72 were extracted in HKMT buffer (20 mM
HEPES-KOH, pH 6.8, 160 mM KOAc, 1 mM MgCl2, 0.5% (wt/vol) Triton X-100),
precleared by centrifugation at 55,000 × g for 10 min at 4 °C and the supernatant
was used for pull-down reactions, as described above. For direct binding assays
between GST-tagged and MBP-tagged proteins, 20 µg of GST-tagged bait protein
bound to 20 µL of glutathione resin was incubated with 20 µg MBP-tagged protein
in HMNT buffer supplemented with 100 µg/mL bovine serum albumin for 4 h at
4 °C with agitation. Bound proteins were eluted from the glutathione beads with
elution buffer (50 mM Tris-Cl pH 8.1, 25 mM reduced glutathione) for 10 min,
followed by trichloroacetic acid precipitation and analyzed by SDS-PAGE with
western blotting or Coomassie blue staining. Uncropped versions of western blots
are shown in Supplementary Figure 9.
Surface plasmon resonance. Experiments were performed using the ProteOn
XPR36 instrument (Bio-Rad Laboratories) using the high-capacity GLH chip
(Bio-Rad). Running buffer was 150 mM NaCl, 10 mM HEPES, 0.02% (wt/vol)
Tween-20, pH 7.4. Two channels were activated with 250 μL of 25 mM
N-ethyl-N′-(3-dimethylaminopropyl) carbodiimide (EDC) and 8 mM sulfo-
N-hydroxysuccinimide (sulfo-NHS) at a ﬂow rate of 30 μL/min. Anti-MBP anti-
body was bound to both channels to a ﬁnal level of approximately 16,000 response
units (RUs). MBP-tagged Scyl1 was then captured on the second channel only to a
ﬁnal level of 3000 RUs. Binding of GST-tagged GORAB variants to both channels
at 30 nM concentration and a ﬂow rate of 100 μL/min was allowed to occur for
120 s followed by 600 s disassociation, using the ﬁrst channel as a reference. All
binding sensorgrams were collected, processed and analyzed using the integrated
ProteOn Manager software (Bio-Rad Laboratories).
Liposome recruitment assay. All lipids were purchased from Avanti Polar Lipids.
To make 3 mM ﬁnal ‘Golgi lipid’ mixture in CHCl3, the following lipids were used:
43 mol% phosphatidylcholine from bovine liver, 19 mol% phosphatidylethanola-
mine from bovine liver, 5 mol% phosphatidylserine from bovine brain, 10 mol%
phosphatidylinositol from bovine liver, 7 mol% sphingomyelin from bovine brain
and 16 mol% cholesterol from wool grease. The liposome suspension was then
subjected to ﬁve cycles of freezing and thawing using dry ice in isopropanol and
37 °C water bath. For a single experiment, 500 µM liposomes were rehydrated in
assay buffer (50 mM HEPES pH 7.2, 120 mM KOAc, 1 mM MgCl2) and sized via
extrusion through a polycarbonate ﬁlter with a pore size of 200 nm (GE Health-
care). Liposomes were then incubated at 37 °C for 20 min with 10 µM MBP-Scyl1
or MBP-IPIP27A, 10 µM recombinant mouse coatomer isotype γ2ζ1 (CMγ2ζ1;
produced in Sf9 insect cells18) and 5 µM recombinant N-myristoylated human
ARF1 (puriﬁed to near homogeneity), some additionally supplemented with
100 µM GTPγS in a ﬁnal volume of 100 µL. Next, samples were adjusted to 35%
(wt/wt) sucrose, overlaid with 300 µL 30% (wt/wt) sucrose and buffer and cen-
trifuged for 1 h at 256,000 × g in a SW60 rotor (Beckman Coulter). The top fraction
(100 µL) containing liposomes was collected, diluted in 500 µL assay buffer, pelleted
in a TLA55 rotor (Beckman Coulter) for 1 h at 91,000 × g and analyzed by SDS-
PAGE with western blotting.
Immunoﬂuorescence microscopy. Cells were grown on glass coverslips and
washed twice with phosphate-buffered saline (PBS) prior to ﬁxation in 3% (wt/vol)
paraformaldehyde (PFA) in PBS for 20 min at RT. Cells were then washed with
PBS and the excess of PFA was quenched with glycine. The cells were permeabi-
lized by 4 min of incubation in 0.1% (wt/vol) Triton X-100 in PBS or in 0.05%
(wt/vol) SDS in PBS. Cells were incubated with primary antibody solution for 1 h at
RT and incubated three times with PBS for 5 min. Then, coverslips were incubated
for 1 h with secondary antibody solution (often supplemented with 200 ng/mL of
the DNA dye Hoechst 33342) and incubated three times with PBS for 5 min and
twice in ddH20 for 5 min. Coverslips were dried before mounting in Mowiol 4–88
(0.1 M Tris-Cl, pH 8.5, 10% (wt/vol) Mowiol 4–88, 25% (wt/vol) glycerol). Pre-
pared slides were analyzed using an Olympus BX60 upright microscope equipped
with a MicroMax cooled, slow-scan CCD camera (Princeton Instruments) driven
by Metaview software (University Imaging Corporation). Images were processed
using ImageJ software (MacBiophotonics).
Stimulated emission depletion (STED) microscopy. Cells were grown on pre-
cision glass coverslips (No. 1.5H; Paul Marienfeld), ﬁxed and stained as described
above. Images were collected on a Leica TCS SP8 AOBS inverted gSTED micro-
scope using a 100×/1.40 Plan Apo objective. The confocal settings were as follows:
pinhole 1 Airy unit, scan speed 400 Hz unidirectional and format 2048 × 2048.
STED images were collected using hybrid detectors with the following detection
mirror settings: Alexa 488: 498–542 nm; Alexa-549: 564–619 nm; Alexa-
647:646–713 nm using the 490 nm, 555 nm and 635 nm excitation laser lines and
592 nm, 660 nm and 775 nm depletion laser lines, respectively. STED images were
collected sequentially and deconvolved using Huygens Professional (Scientiﬁc
Volume Imaging).
Fluorescence recovery after photobleaching. HeLa GFP-GalNAc-T2, HeLaM
GFP-GORAB or HeLaM cells transiently expressing GFP-Scyl1 were grown in
35 mm glass bottomed dishes (MatTek Corporation). The medium was changed to
CO2-independent medium supplemented with 10% FBS and 1 mM L-glutamine
just before FRAP analysis. Images were acquired using a CSU-X1 spinning disc
confocal (Yokagowa) on a Zeiss Axio-Observer Z1 microscope with a 150×/1.45
numerical aperture oil immersion TIRF objective (Olympus), Evolve EMCCD
camera (Photometrics) and motorized XYZ stage (Applied Scientiﬁc Instru-
mentation). The 488 nm laser was controlled using an AOTF through the laserstack
(Intelligent Imaging Innovations) allowing both rapid ‘shuttering’ of the laser and
attenuation of the laser power. FRAP was carried out at 37 °C using the FRAP
imaging module of the Slidebook application (Intelligent Imaging Innovations). A
5 µm rectangular region of interest was deﬁned and photobleached at a high laser
power to result in >80% reduction in ﬂuorescence intensity. Recovery was mon-
itored by measuring ﬂuorescence intensity at 3 s intervals for a total period of
3 min. FRAP recovery curves were analyzed using FRAPAnalyser software (http://
actinsim.uni.lu/; University of Luxembourg, Luxembourg).
Metabolic labeling with alkyne-tagged sialic acid. ManNAl was synthesized
according to optimized procedures46. Cells were grown in DMEM supplemented
with 10% FBS and 1 mM L-glutamine containing 500 µM of ManNAl for 10 h
before ﬁxation of cells with 4% (wt/vol) PFA. Cells were permeabilized in PBS with
0.1% Triton X-100 for 4 min and incubated with 100 µL/coverslip of a freshly
prepared click solution (100 mM K2HPO4, 2.5 mM sodium ascorbate, 150 µM
CuSO4, 0.3 mM BTTAA, 10 µM AzidoFluor 545). Copper-catalyzed azide-alkyne
[3+2] cycloaddition (CuAAC) was performed for 45 min in the dark at room
temperature with gentle shaking. Cells were then stained with antibodies as
described above. Images were acquired on a Ti inverted microscope (Nikon) using
a 60×/1.40 Plan Apo objective, Proscan II motorized stage (Prior Scientiﬁc) and R6
CCD camera (QImaging). A SpectraX LED light engine (Lumencore), quad
dichroic (Semrock) and motorized emission ﬁlter wheel (Prior Scientiﬁc) with
single bandpass ﬁlters for FITC, TRITC and Cy5 (Semrock) were used to collect
image sequences at each position in the tile. Images were acquired and then aligned
and stitched using NIS Elements software (Nikon). These stitched images were
then exported as a single TIFF image for further processing in Fiji software. The
amount of intra-Golgi incorporated alkyne-tagged sialic acid was measured by
comparing ﬂuorescence intensity levels with reference to the Golgi marker TGN46.
GORAB staining was employed to discriminate between WT and GO ﬁbroblasts.
Immunoﬂuorescence-based lectin-binding assays. The following method was
adapted from Willet et al.73. Human dermal ﬁbroblasts were grown on glass
coverslips to 90% conﬂuency. Cells were rinsed twice with pre-chilled PBS and
incubated with it for 15 min in order to prevent endocytosis of glycosylated plasma
membrane proteins. Next, cells were incubated in FITC-conjugated MAL or SNA
lectin solution (20 µg/mL; Vector Laboratories) for 20 min in the cold room.
Coverslips were washed three times with pre-chilled PBS and incubated with pre-
chilled 4% (wt/vol) PFA solution prepared in PBS for 20 min. Cells were washed
three times with PBS and excess PFA was quenched by addition of glycine. Cov-
erslips were washed with ddH20, left at RT to dry and mounted using Mowiol 4–88.
Samples were imaged on a Ti inverted microscope (Nikon).
Flow cytometry. Human skin ﬁbroblasts were grown on 10 cm dishes to 100%
conﬂuency. Cells were washed with pre-warmed PBS and detached using pre-
warmed Accutase (Sigma). Next, cells were washed twice with PBS, resuspended in
pre-chilled PBS and incubated for 15 min on ice followed by incubation in MAL or
SNA lectin solution (20 µg/mL; Vector Laboratories) for 30 min at 4 °C. Next, cells
were washed three times with PBS, resuspended in 400 µL of ice-cold PBS and
analyzed using a Beckman Coulter Cyan ADP ﬂow cytometer with a 488 nm laser.
Propidium iodide was added to exclude non-viable cells from the ﬂow cytometry
analysis. Data were analyzed using Summit V4.3 software (Beckman Coulter).
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Electron microscopy (EM). For morphological analysis, human skin ﬁbroblasts
were grown on glass coverslips and ﬂat embedded. Serial thin sections (60 nm)
were cut parallel to the coverslip and sections at approximately equal intervals were
imaged with Jeol JEM-1400 microscope operated at 80 kV. Images were acquired
with Gatan Orius SC 1000B camera. For pre-embedding immuno-EM, cells were
ﬁxed with PLP (periodate-lysine-paraformaldehyde) ﬁxative for 2 h, permeabilized
with 0.01% saponin, labeled with anti-GORAB rabbit antibody followed by nano-
gold-conjugated anti-rabbit IgG Fab-fragments (Nanoprobes), post-ﬁxed with 1%
glutaraldehyde and quenched with 50 mM glycine. Nano-gold particles were then
intensiﬁed using the HQ SILVER Enhancement kit (Nanoprobes, Cat. No. 2012)
followed by gold toning in subsequent incubations in 2% NaAcetate, 0.05%
HAuCl4 and 0.3% Na2S2O3•5H2O. The cells then were processed for EM and
imaged as described above. Peroxidase cytochemistry was performed on HeLa
SialylT-HRP cells that were seeded on Aclar coverslips (Agar Scientiﬁc) and
transfected with control, GORAB, Scyl1 or COG3 siRNAs. At 72 h after trans-
fection, cells were ﬁxed with 2% (wt/vol) paraformaldehyde, 1.5% (wt/vol) glu-
taraldehyde solution made in 0.1 M sodium cacodylate buffer, pH 7.4, for 20 min at
room temperature (RT). Samples were then washed twice with 0.1 M sodium
cacodylate buffer for 3 min and 5 times with 50 mM Tris-buffer, pH 7.6, for 5 min.
Samples were incubated in freshly prepared 0.1% (wt/vol) 3,3'-diaminobenzidine
(DAB; TAAB Laboratories Equipment) made in 50 mM Tris-buffer, pH 7.6, and
supplemented with 0.0002% (vol/vol) H2O2 for 30 min at RT protected from light.
Samples were washed 3 times with 50 mM Tris-buffer, pH 7.6 for 5 min and twice
with 0.1 M sodium cacodylate buffer for 5 min. Sections were cut with Reichert
Ultracut ultramicrotome and observed with FEI Tecnai 12 Biotwin microscope at
100 kV accelerating voltage. Images were taken with Gatan Orius SC1000 CCD
camera.
Yeast two-hybrid assays. Yeast two-hybrid assays were performed using
Matchmaker Gold system (Clontech Laboratories). First, bait-containing and prey-
containing plasmids were co-transformed into the yeast strain Y2HGold with 500
ng of a bait DNA plasmid and 500 ng of a prey DNA plasmid alongside 50 µg of
denatured herring sperm DNA acting as a carrier DNA and plated on double drop-
out agar plates (SD/-Leu/-Trp). Three single colonies per test condition were
inoculated into 4 mL of liquid SD/-Leu/-Trp medium supplemented with glucose
and grown for 2 days at 30 °C with 150 rpm agitation. A 10 µL innoculation loop
was used to transfer the liquid yeast culture to a square on a double drop-out (SD/-
Leu/-Trp) and quadruple drop-out (SD/-Ade/-His/-Leu/-Trp) agar plates. The
plates were incubated at 30 °C and growth was monitored for a period of 7 days.
SD/-Leu/-Trp agar plate was used as a growth control and the selective growth on
the SD/-Ade/-His/-Leu/-Trp agar plate indicated interaction between the bait and
the prey.
Glycan mass spectrometry. For proﬁling of control and GO ﬁbroblasts N-glycans
were isolated using ﬁlter-aided N-glycan separation (FANGS). Fibroblasts were
grown until they were conﬂuent, the medium was removed and cells were washed
6 times with PBS. Cells were scraped in 1 mL PBS using a cell scraper and and
centrifuged at 16,000×g for 5 min at 4 °C. The cell pellet was dissolved in 10×
volume of lysis buffer (4% (wt/vol) SDS, 100 mM Tris, pH 7.6, 100 mM dithio-
threitol) and boiled for 5 min at 95 °C followed by centrifugation at 16,000 × g for
5 min at RT. Urea buffer (8 M in 100 mM Tris-Cl pH 8.5) was added to super-
natants at a 10:1 volume ratio and samples were passed through ultraﬁltration
membranes (Amicon Ultra-0.5, Merck) by centrifugation at 15,000 × g for 10 min
at RT. Samples retained above ﬁlter membranes were subjected to a series of
washes combined with centrifugation at 15,000 × g for 10 min at RT: (1) washed
twice with 250 μL of urea buffer, (2) incubated with 300 μL of urea buffer sup-
plemented with 40 mM iodoacetamide for 15 min before centrifugation, (3) washed
once with 250 μL of 8M urea and (4) washed four times with 250 μL of 50 mM
NH4HCO3. Filter membranes were subsequently incubated with 8 U of PNGase F
in 100 μL of 50 mM NH4HCO3 for 16 h at 37 °C followed by centrifugation at
15,000 × g for 15 min at RT and washed twice with 250 μL water. Samples above
ﬁlter membranes containing released N-glycans were transferred to glass tubes and
dried in a vaccum centrifuge (Ultraﬂex Power Technologies). Permethylation of
glycans was performed as follows: samples were dissolved in 600 μL of DMSO,
supplemented with 25 mg of NaOH and mixed until completely dissolved. Then,
iodomethane was added in the following manner: 375 μL followed by incubation
for 10 min at RT, 375 μL followed by incubation for 10 min at RT and 750 μL
followed by incubation for 20 min at RT. The reaction was quenched by addition of
1.5 mL of 1 g/mL Na2S2O3 solution and 1.5 mL of dichloromethane followed by
extensive vortexing. Samples were left undisturbed to allow phase separation and
the lower, organic, layer was taken to fresh glass tubes and dried under vacuum.
Samples were dissolved in 20 μL of methanol. Then, 2 μL of the sample was mixed
with 1 μL of 0.5 M sodium nitrate (in 70% methanol) and 2 μL of 20 mg/mL
2,5-dihydroxybenzoic acid (in 70% methanol). Next, 2 μL of this mix was spotted
onto a ground steel MALDI target plate (Bruker) and allowed to air dry. Imme-
diately afterwards, 0.2 μL of ethanol was added to the spot and left to air dry for re-
crystallization. Glycans were then permethylated and analyzed by mass spectro-
metry using a Bruker Daltonics ultraﬂex III TOF/TOF mass spectrometer equipped
with a Smartbeam laser used in positive-ion mode over the m/z range 800–5000,
with 4000 laser shots in steps of 800, which were summed to give one spectrum per
spot. The Smartbeam™ laser power was set to 50–65%. The Bruker FlexAnalysis
software was used to smooth the data (Savitzky–Golay). Following smoothing, all
glycan signal intensities assigned a signal-to-noise of >3 by the software were
selected, and those belonging to the same species (same isotopic envelope) were
summed to generate a total signal intensity for each glycan species. Total signal
intensities for each glycan were normalized to the total glycan signal within a
spectrum, and normalized intensities averaged between spectra collected for the
same cell line.
For glycan proﬁling of mouse skin samples, glycans were isolated from E18.5
control and homozygous GorabNull47. The mice were bred with local ethical
approval from Landesamt für Gesundheitsschutz und Technische Sicherheit
(LaGeTSi), Berlin, Germany (approval number G0213/12). The proteins/
glycoproteins were then dialyzed against 50 mM ammonium hydrogen carbonate
at 4 °C. After lyophilization, glycoproteins were dissolved in 500 µL of 600 mM
Tris/HCl, pH 8.2, and denatured by guanidine hydrochloride (6 M ﬁnal
concentration). The sample was reduced using 1 mg of dithiothreitol and incubated
at 50 °C for 2 h. After addition of 6 mg of iodoacetamide, the sample was incubated
at room temperature for 90 min in the dark. The sample was then dialyzed against
50 mM ammonium hydrogen carbonate at 4 °C and lyophilized. The reduced
carboxyamidomethylated proteins were digested with L-1-tosylamide-2-
phenylethylchloromethylketone (TPCK) bovine pancreas trypsin (EC 3.4.21.4,
Sigma) with an enzyme-to-substrate ratio of 1:50 (by mass), and the mixture was
incubated for 24 h at 37 °C in 50 mM ammonium bicarbonate buffer, pH 8.4. The
reaction was terminated by boiling for 5 min before lyophilization. PNGase F
digestion was carried out in ammonium bicarbonate buffer (50 mM) for 16 h at
37 °C. The reaction was terminated by lyophilization and the products were
puriﬁed on C18-Sep-Pak to separate the N-glycans from the de-N-glycosylated
peptides. After conditioning the C18-Sep-Pak by sequential washing with methanol
(5 ml), and 5% acetic acid (2 × 5 ml), the sample was loaded onto the Sep-Pak and
the N-glycans were eluted with 2 ml of 5% acetic acid. N-linked glycans were then
permethylated using the sodium hydroxide procedure. MALDI-TOF-MS (matrix-
assisted laser desorption/ionization–time-of-ﬂight–mass spectrometry)
experiments were carried out on Voyager Elite DE-STR Pro instrument
(PersSeptive Biosystem, Framingham, MA, USA) equipped with a pulsed nitrogen
laser (337 nm) and a gridless delayed extraction ion source. The spectrometer was
operated in positive reﬂectron mode by delayed extraction with an accelerating
voltage of 20 kV and a pulse delay time of 200 ns and a grid voltage of 66%. All the
spectra shown represent accumulated spectra obtained by 400–500 laser shots.
Sample was prepared by mixing a 1 μL aliquot (5–10 pmol) with 1 μL of 10 mg/mL
2,5-dihydroxybenzoic acid (in 50% methanol).
The assignment of glycan species for both human ﬁbroblast and mouse skin
samples was based on accurate m/z measurements, precisely matching to
theoretical masses of the glycan species measured, taking into account the known
ionization of these glycans, and on the basis of the well-accepted biosynthetic route
for N-glycans74,75.
Statistical analysis. Statistical analyses were conducted using GraphPad Prism
software (GraphPad Software). D’Agostino–Pearson and Shapiro–Wilk tests were
used for comparison of the distribution of data with a Gaussian distribution.
Depending on the result, an unpaired t-test or Mann–Whitney test was performed.
In the case of an unpaired t-test, equality of variances between two groups was tested
with an F-test. One-way analysis of variance with Dunnett’s test was performed for
multiple group comparisons and the equality of group variances were examined with
the Brown–Forsythe test. Quantiﬁcation of SialylT-HRP distribution in siRNA-
treated HeLa SialylT-HRP cells was performed using the chi-square test. Statistical
signiﬁcance cut-offs were set as follows: *p ≤ 0.05, **p < 0.01 and ***p < 0.001.
Data availability
The data that support the ﬁndings of this study are available from the corre-
sponding author upon request.
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